Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery

被引：6

作者：

Berger, Jay ^{[1
]}

Schwartz, Joseph ^{[1
]}

Ramachandran, Sujatha ^{[1
]}

Leff, Jonathan D. ^{[1
]}

机构：

[1] Montefiore Hosp & Med Ctr, Dept Anesthesiol, Bronx, NY USA

来源：

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2019年 / 33卷 / 12期

关键词：

von Willebrand disease; vWD; von Willebrand factor; vWF; cardiac surgery; acquired von Willebrand syndrome; ABO BLOOD-GROUP; NORMAL PLATELET TRANSFUSION; VENTRICULAR ASSIST DEVICES; BLEEDING ASSESSMENT-TOOL; FACTOR-VIII; ADVERSE EVENTS; HEMOPHILIA-A; DESMOPRESSIN; DIAGNOSIS; MANAGEMENT;

D O I：

10.1053/j.jvca.2019.08.025

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：3446 / 3457

页数：12

共 82 条

[1] The vWF content of factor VIII concentrates [J].

Agrawal, YP ;

Dzik, W .

TRANSFUSION, 2001, 41 (01) :153-154

[2] Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system [J].

Agren, Anna ;

Holmstrom, Margareta ;

Schmidt, David E. ;

Hosokawa, Kazuya ;

Blomback, Margareta ;

Hjemdahl, Paul .

THROMBOSIS AND HAEMOSTASIS, 2017, 117 (01) :75-82

[3] Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms [J].

Albanez, S. ;

Ogiwara, K. ;

Michels, A. ;

Hopman, W. ;

Grabell, J. ;

James, P. ;

Lillicrap, D. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (05) :953-963

[4] Reduced von Willebrand factor survival in type Vicenza von Willebrand disease [J].

Casonato, A ;

Pontara, E ;

Sartorello, F ;

Cattini, MG ;

Sartori, MT ;

Padrini, R ;

Girolami, A .

BLOOD, 2002, 99 (01) :180-184

[5] von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding [J].

Casonato, Alessandra ;

Sponga, Sandro ;

Pontara, Elena ;

Cattini, Maria Grazia ;

Basso, Cristina ;

Thiene, Gaetano ;

Cella, Giuseppe ;

Daidone, Viviana ;

Gerosa, Gino ;

Pagnan, Antonio .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (01) :58-66

[6] Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD [J].

Castaman, Giancarlo ;

Lethagen, Stefan ;

Federici, Augusto B. ;

Tosetto, Alberto ;

Goodeve, Anne ;

Budde, Ulrich ;

Batlle, Javier ;

Meyer, Dominique ;

Mazurier, Claudine ;

Fressinaud, Edith ;

Goudemand, Jenny ;

Eikenboom, Jeroen ;

Schneppenheim, Reinhard ;

Ingerslev, Jorgen ;

Vorlova, Zdena ;

Habart, David ;

Holmberg, Lars ;

Pasi, John ;

Hill, Frank ;

Peake, Ian ;

Rodeghiero, Francesco .

BLOOD, 2008, 111 (07) :3531-3539

[7] Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality [J].

Castaman, Giancarlo ;

Federici, Augusto B. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (05) :478-482

[8]

CASTILLO R, 1991, BLOOD, V77, P1901

[9] Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect [J].

Castillo, R ;

Escolar, G ;

Monteagudo, J ;

AznarSalatti, J ;

Reverter, JC ;

Ordinas, A .

TRANSFUSION, 1997, 37 (08) :785-790

[10] Management of acquired von Willebrand syndrome [J].

Charlebois, Janie ;

Rivard, Georges-Etienne ;

St-Louis, Jean .

TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (06) :721-723

← 1 2 3 4 5 6 7 8 9 →